Saxenda
Liraglutide
Saxenda (liraglutide) is a once-daily GLP-1 receptor agonist originally developed for type 2 diabetes but later approved for chronic weight management in adults with obesity or overweight plus a weight-related condition. It works by slowing gastric emptying, reducing appetite, and improving satiety, helping patients consume fewer calories and lose weight gradually. Saxenda has robust long-term safety and efficacy data, making it a trusted earlier-generation GLP-1 option for weight loss. While typically less potent than weekly GLP-1s like semaglutide, it remains an important treatment choice for patients preferring daily dosing or those who respond well to liraglutide specifically.
- Manufacturer: Novo Nordisk
- Primary Use: Chronic weight management
- Form: Injectable
Common Side Effects
The most common side effects of Saxenda may include:
- Nausea
- Vomiting
- Diarrhea
- Headache
- Fatigue
This is not a complete list. Always consult with your healthcare provider about potential side effects.
Medical Disclaimer
The information provided for Saxenda is for informational purposes only and is not a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment. Read our full disclaimer.